Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Non-US bivalent oral polio vaccine (types 1 and 3)

Known as: OPV bivalent 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
ABSTRACT Bivalent rLP2086 (Trumenba), a vaccine for prevention of Neisseria meningitidis serogroup B (NmB) disease, was licensed… Expand
Review
2018
Review
2018
Background: In February 2015, two unlinked culture-confirmed cases of Neisseria meningitidis serogroup B (MenB) disease occurred… Expand
2017
2017
ABSTRACT Objective: To outline the reasoning behind use of bivalent rLP2086 in a Rhode Island college meningococcal B disease… Expand
Highly Cited
2016
Highly Cited
2016
Background Neisseria meningitidis serogroup B (MnB) is a leading cause of invasive meningococcal disease in adolescents and young… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
2016
2016
Key points Concomitant administration of bivalent rLP2086 (Trumenba [Pfizer, Inc] and diphtheria, tetanus, and acellular… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
2016
2016
Background: This study in healthy adolescents (11 to <18 years) evaluated coadministration of quadrivalent human papillomavirus… Expand
Review
2012
Review
2012
More than 2 million AIDS-related deaths occurred globally in 2008, and more than 33 million people are living with HIV/AIDS… Expand
  • table 1
  • figure 1
2007
2007
Abstract:  We recently reported that the pathogenesis of pemphigus vulgaris (PV), an autoimmune blistering skin disorder, is… Expand
Highly Cited
2006
Highly Cited
2006
BACKGROUND Effective vaccination against HPV 16 and HPV 18 to prevent cervical cancer will require a high level of sustained… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
2004
2004
OBJECTIVE To evaluate the efficacy of a modified-live virus (MLV) combination vaccine containing type 1 and type 2 bovine viral… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3